CRISPR-Cas9 system: a novel and promising era of genotherapy for beta-hemoglobinopathies, hematological malignancy, and hemophilia Abdulfatah M. AlayoubiZakaria Y. KhawajiFrançois E. Mercier Review Article 22 September 2023 Pages: 1805 - 1817
Coagulation and Inflammation in COVID-19: Reciprocal Relationship between Inflammatory and Coagulation Markers Rasoul EbrahimiFatemeh NasriTahereh Kalantari Review Article 13 February 2024 Pages: 1819 - 1831
Therapeutic progress in relapsed/refractory multiple myeloma Qi ChenMin ZhangYamin Tan Review Article 13 April 2024 Pages: 1833 - 1841
Recent progress in chimeric antigen receptor therapy for acute myeloid leukemia Xiangyu WangYanming ZhangShengli Xue Review Article 21 February 2024 Pages: 1843 - 1857
Waldenström macroglobulinemia: a review of pathogenesis, current treatment, and future prospects Bushra GhafoorShameera Shaik MasthanFaiz Anwer Review Article 06 July 2023 Pages: 1859 - 1876
A nomogram model for predicting the efficacy of cyclosporine in patients with pure red cell aplasia Liyan YangHaiyue NiuRong Fu Original Article 03 February 2024 Pages: 1877 - 1885
Impact of genotype on multi-organ iron and complications in patients with non-transfusion-dependent β-thalassemia intermedia Antonella MeloniLaura PistoiaFilippo Cademartiri Original Article 06 April 2024 Pages: 1887 - 1896
Comparison of human leukocyte antigen in patients with paroxysmal nocturnal hemoglobinuria of different clone sizes Zhuxin ZhangQinglin HuBing Han Original Article 15 April 2024 Pages: 1897 - 1907
Expert consensus on the management of infusion-related reactions (IRRs) in patients with sickle cell disease (SCD) receiving crizanlizumab: a RAND/UCLA modified Delphi panel Julie KanterKenneth I. AtagaMichael S. Broder Original Article 20 April 2024 Pages: 1909 - 1917
Inhibition of NRF2 signaling overcomes acquired resistance to arsenic trioxide in FLT3-mutated Acute Myeloid Leukemia Daniel Zechariah Paul JebanesanRaveen Stephen Stallon IllangeswaranPoonkuzhali Balasubramanian Original Article 17 April 2024 Pages: 1919 - 1929
Ruxolitinib Adherence in Myelofibrosis and Polycythemia Vera: the “RAMP” Italian multicenter prospective study F. PalandriG. AuteriG. A. Palumbo Research Open access 13 March 2024 Pages: 1931 - 1940
Incidence of pleural effusion with dasatinib and the effect of switching therapy to a different TKI in patients with chronic phase CML Akriti G JainQuinto GesiottoKendra Sweet Research Open access 18 April 2024 Pages: 1941 - 1945
Association of JAK2V617F allele burden and clinical correlates in polycythemia vera: a systematic review and meta-analysis Chih-Cheng ChenJustin L. ChenHsin-An Hou Research Open access 23 April 2024 Pages: 1947 - 1965
GLI1 polymorphisms influence remission rate and prognosis of young de novo acute myeloid leukemia patients treated with cytarabine-based chemotherapy Yanfeng LiuYi LiuXiaoping Chen Research 27 April 2024 Pages: 1967 - 1977
1q21+ is associated with poor prognosis in newly diagnosed multiple myeloma patients with extramedullary disease: a retrospective study Shuang GaoFei DongHongmei Jing Original Article 11 January 2024 Pages: 1979 - 1987
Immune profiling of patients with extranodal natural killer/T cell lymphoma treated with daratumumab Min QingTianyuan ZhouRaluca I. Verona Original Article Open access 18 January 2024 Pages: 1989 - 2001
Modified R-BAC plus BTK inhibitor regimen in newly diagnosed young patients with mantle cell lymphoma: a real-world retrospective study Wenqi LiYu ChangLei Zhang Original Article 03 February 2024 Pages: 2003 - 2012
Low incidence of tumor lysis syndrome in elderly patients with chronic lymphocytic leukemia treated with venetoclax under real-world conditions: results from the prospective observational VeRVe study Ingo SchwanerThomas KuhnDavide Rossi Original Article Open access 29 February 2024 Pages: 2013 - 2020
Secondary central nervous system involvement in patients with diffuse large B-cell lymphoma treated with rituximab combined CHOP therapy – a supplementary analysis of JCOG0601 Kazuyuki ShimadaKen OhmachiHirokazu Nagai Original Article Open access 27 January 2024 Pages: 2021 - 2031
Patterns and prognostic impact of CNS infiltration in adults with newly diagnosed acute lymphoblastic leukemia Luiza Lapolla PerrusoElvira VellosoWellington Fernandes Silva Original Article 05 January 2024 Pages: 2033 - 2039
Nomogram for predicting survival of patients with diffuse large B-cell lymphoma Keiichiro FujiiAtsushi InagakiHiroshi Inagaki Original Article 27 February 2024 Pages: 2041 - 2050
Comparable outcomes of allogeneic peripheral blood versus bone marrow hematopoietic stem cell transplantation from a sibling donor for pediatric patients Bo Kyung KimKyung Taek HongHyoung Jin Kang Original Article Open access 10 April 2024 Pages: 2051 - 2058
Systemic inflammatory autoimmune disease before allogeneic hematopoietic stem cell transplantation is a risk factor for death in patients with myelodysplastic syndrome or chronic myelomonocytic leukemia Kumiyo TazoeNaonori HaradaHirohisa Nakamae Original Article 25 April 2024 Pages: 2059 - 2072
Efficacy and prognostic factors of allogeneic hematopoietic stem cell transplantation treatment for adolescent and adult Tlymphoblastic leukemia /lymphoma: a large cohort multicenter study in China Lan LuoYang JiaoHongmei Jing Research 06 April 2024 Pages: 2073 - 2087
Combining serum microRNAs and machine learning algorithms for diagnosing infectious fever after HSCT Wenwei ShaoYixuan WangXiaolei Pei Research 01 May 2024 Pages: 2089 - 2102
Unrelated umbilical cord blood transplantation with low-dose anti-thymocyte globulin for children with severe aplastic anemia: A case series Mengze HuJunhui LiLitian Xuan Research 24 April 2024 Pages: 2103 - 2111
Quality of life after immune suppressive therapy in aplastic anemia Iris N. LommerseChris HinnenJennifer M.-L. Tjon Original Article Open access 05 April 2024 Pages: 2113 - 2121
Efficacy and safety of tixagevimab/cilgavimab as passive immunisation against COVID-19 infections in patients with hematological malignancies Patrick ReimannVerena PetzerMagdalena Anna Benda Research 02 March 2024 Pages: 2123 - 2131
Pharmacogenetic guided versus standard warfarin dosing for routine clinical care with its pharmacoeconomic impact: a randomized controlled clinical trial Aishwarya AnandNaveen C HegdeSamir Malhotra Research 18 April 2024 Pages: 2133 - 2144
Analysis of four hereditary protein C deficiencies associated with vascular thromboembolism Xuanyu ChenChengxiang YuanMing Zou Research 04 March 2024 Pages: 2145 - 2155
Triple a score (AAA: age, absolute neutrophil count and absolute lymphocyte count) and its prognostic utility in patients with overt fibrotic and prefibrotic myelofibrosis Marko LucijanicIvan KrecakRajko Kusec Correspondence 23 April 2024 Pages: 2157 - 2159
Cerebral infarction in a patient with inhibitor-positive hemophilia B treated with plasma-derived factor VIIa and factor X mixture Katsuyoshi ShimozawaHiroshi YagasakiIchiro Morioka Correspondence 13 April 2024 Pages: 2161 - 2162
Letter to Editor: Treatment with the apoptosis inhibitor asunercept reduces clone sizes in patients with lower risk myelodysplastic neoplasms Syeda Dua e Zehra ZaidiSyeda Mahrukh Fatima ZaidiBurhanuddin Sohail Rangwala Correspondence 23 April 2024 Pages: 2163 - 2164
Thiotepa-busulfan-fludarabine-based conditioning as a promising approach prior to allogeneic hematopoietic stem cell transplantation in patients with blastic plasmacytoid dendritic cell neoplasm Xianbo HuangShasha WangJiejing Qian Case Report 08 April 2024 Pages: 2165 - 2168
Could it be VEXAS? Hippolyte GuerineauMilena KohnAurélie Cabannes-Hamy Case Report 09 April 2024 Pages: 2169 - 2171
Diagnosing aceruloplasminemia: navigating through red herrings Zeni KharelHimal KharelPradyumna D. Phatak Case Report 19 April 2024 Pages: 2173 - 2176
Systematic analysis of copper, zinc, and selenium levels in JAK2 V617F-positive myeloproliferative neoplasms Velizar ShivarovGergana TsvetkovaMilena Ivanova Letter to the Editor 17 January 2024 Pages: 2177 - 2179
Cystatin F a potential diagnostic biomarker in acute promyelocytic leukemia Hamenth Kumar PalaniSaravanan GanesanVikram Mathews Letter to the Editor 01 March 2024 Pages: 2181 - 2183